Oak Brook, IL – Volume 33 of SLAS Discovery features one review, three original research articles and one entry in the upcoming Special Issue on Biomolecular Condensates as Targets for Drug Discovery .
This upcoming Special Issue, guest edited by Charles P. Hart, PhD (University of California, San Francisco), will explore the role of biomolecular condensates in diseases and the potential for drug discovery by modulating their formation, stability or dissolution in neurodegenerative, cancer and inflammatory disorders.
Access to this issue of SLAS Discovery is available at https://www.slas-discovery.org/issue/S2472-5552(25)X0004-6
*****
SLAS Discovery reports how scientists develop and use novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. The journal focuses on drug discovery sciences with a strong record of scientific rigor and impact, reporting on research that:
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2024 Impact Factor 2.7. Editor-in-Chief Robert M. Campbell, Ph.D., Grove Biopharma, Inc., Chicago, IL (USA)
###
SLAS DISCOVERY
1-Jun-2025